Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson acquired 32,640 shares of Dr. Martens stock in a transaction dated Tuesday, March 25th. The stock was bought at an average price of GBX 54 ($0.70) per share, with a total value of £17,625.60 ($22,692.93).
Giles Wilson also recently made the following trade(s):
- On Tuesday, March 11th, Giles Wilson purchased 269 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 56 ($0.72) per share, with a total value of £150.64 ($193.95).
- On Tuesday, February 11th, Giles Wilson acquired 207 shares of Dr. Martens stock. The stock was bought at an average cost of GBX 73 ($0.94) per share, for a total transaction of £151.11 ($194.55).
- On Monday, January 13th, Giles Wilson acquired 222 shares of Dr. Martens stock. The shares were bought at an average price of GBX 68 ($0.88) per share, with a total value of £150.96 ($194.36).
Dr. Martens Price Performance
LON DOCS opened at GBX 54.15 ($0.70) on Thursday. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27. Dr. Martens plc has a 12 month low of GBX 49.32 ($0.63) and a 12 month high of GBX 99.40 ($1.28). The stock has a market cap of £525.67 million, a price-to-earnings ratio of 7.68, a PEG ratio of 6.40 and a beta of 0.11. The company’s 50 day moving average is GBX 65.28 and its two-hundred day moving average is GBX 63.63.
Dr. Martens Cuts Dividend
Dr. Martens Company Profile
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Stories
- Five stocks we like better than Dr. Martens
- ESG Stocks, What Investors Should Know
- Energy Transfer: Powering Data With Dividends and Diversification
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Qualcomm Stock Is Coiling for a Breakout
- What is a Secondary Public Offering? What Investors Need to Know
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.